SNDX News and Press, Syndax Pharmaceuticals Inc. From 05/15/24

Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors PR Newswire WALTHAM, Mass. , May 15, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of...

2024-05-14 04:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference PR Newswire WALTHAM, Mass. , May 9, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeli...

2024-05-08 16:08:09 ET Syndax Pharmaceuticals, Inc. (SNDX) Q1 2024 Earnings Conference Call May 08, 2024, 08:00 ET Company Participants Sharon Klahre - Head, Investor Relations Michael Metzger - CEO & Director Steve Closter - Chief Commercial Officer Keit...

2024-05-08 07:23:29 ET More on Syndax Pharmaceuticals Syndax Pharmaceuticals: Upcoming Q3 PDUFAs Ignite Hope Syndax Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation Syndax Pharmaceuticals, Inc. (SNDX) Q4 2023 Earnings Call Transcript Crine...

Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update PR Newswire – NDA filing for revumenib in R/R KMT2Ar acute leukemia granted Priority Review under RTOR; PDUFA action date set for September 26, 2024 ȁ...

2024-05-07 14:09:48 ET More on Syndax Pharmaceuticals Syndax Pharmaceuticals: Upcoming Q3 PDUFAs Ignite Hope Syndax Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation Syndax Pharmaceuticals, Inc. (SNDX) Q4 2023 Earnings Call Transcript Crine...

2024-05-04 10:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024 PR Newswire WALTHAM, Mass. , May 1, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an in...

2024-04-24 16:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...